To avoid these nausea triggers, stay on top of water intake before and after activities, take frequent breaks when exercising outside, and give yourself enough time to recover inside or in shaded areas when needed
Overtraining without enough rest, combined with low calorie intake, may lead to a condition called relative energy deficiency in sport (RED-S)
Clinical studies have shown that patients using tirzepatide achieved significant weight loss compared to those using a placebo
The development of rare adverse events, which may not occur until a patient has been on a drug for a number of years, is of concern, but until more patients are followed for an adequate period of time, the true safety of a drug cannot be stated or concluded
2024 FDA Developments Several important FAA and FDA actions occurred in 2024: In January 2024, tirzepatide (Zepbound, Mounjanaro) was added to the FAAs Conditionally Acceptable Weight Loss Medications category, but medical certification required Special Issuance
The answer is almost always simplification